Reaching the New Healthcare Buying Committees
Today’s $42.8B medical device industry has been largely impacted by massive consolidation, which has led to four of the largest medical device companies in the U.S. making up a whopping 73.2% of the market. While merger and acquisition (M&A) has helped companies stay competitive, scale up, diversify and innovate, it hasn’t been a one-size-fits-all solution.
Customer education, the regulatory environment, value-analysis committees, and eroding margins are beyond the scope of M&A activities to address, and amid these challenges, a single issue emerges as most pressing: Medical device companies have lost touch with decision makers and don’t know how, or to whom, they need to influence.
In this white paper, you’ll learn:
- How the world of B2B has changed and the current state of the medical device industry,
- The new ways in which medical device companies can reach and influence their intended audience,
- How to create hyper-personalized messaging, targeted to specific accounts.